top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
The provided text is a newsletter from "Marijuana Moment" dated July 17, 2025. It discusses various developments in cannabis and psychedelic policy. Key points include: the USDA describing marijuana as "medicinal" despite its Schedule I classification; Veterans Affairs Secretary Doug Collins discussing psychedelic therapy access for veterans; a House Armed Services Committee amendment for a psychedelic treatment program status report; a new Pennsylvania marijuana legalization bill; major health groups advocating for continued protection of state medical cannabis laws; the Omaha Tribe of Nebraska legalizing marijuana; Delaware's plan to launch recreational cannabis sales via medical dispensaries; recent ICE raids on Glass House Brands facilities over immigration issues; a House bill to seal marijuana records; a Pennsylvania senator's op-ed on marijuana legalization funding public transit; an investigation into Glass House Brands employing minors; Utah considering increasing medical marijuana purchase limits; New York regulators settling with cannabis businesses over prohibited conduct; Minnesota publishing a list of tax-delinquent cannabis businesses; and the Rhode Island Cannabis Control Commission meeting. It also mentions an upcoming cannabis festival in New York City, Slovenia approving medical cannabis legislation, studies on medical cannabis for neurological disabilities and adolescent cannabidiol treatment, Flowhub's new ecommerce solution, and Theo Von's podcast about ibogaine.

Feds Acknowledge Medicinal Cannabis Value but Keep It in Schedule I

Jul 17, 2025

Source:

Tom Angell

Marijuana Moment

The federal government is sending some mixed signals that have the cannabis community doing a double-take. A USDA database recently labeled marijuana as "medicinal," a refreshing bit of honesty that directly contradicts its ongoing Schedule I status. Meanwhile, the VA is finally exploring psychedelic therapies for veterans, and Congress is pushing for reports on MDMA treatments for PTSD. On the state level, Pennsylvania is seeing fresh momentum with another legalization bill, and the Omaha Tribe in Nebraska has officially legalized both medical and recreational use, marking a historic first for the state.

This is a massive deal for everyday tokers because it shows the federal "no medical value" argument is crumbling from the inside. When government agencies start acknowledging what the community has known for decades—that this plant is medicine—it paves the way for better access and lower hurdles for patients everywhere. Even with some regulatory drama in California and New York, the overall trend is leaning toward a more open and scientifically-backed future for our favorite herb.

Recent Reviews

bottom of page